Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SCLN > SEC Filings for SCLN > Form 8-K/A on 5-Apr-2013All Recent SEC Filings

Show all filings for SCICLONE PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K/A for SCICLONE PHARMACEUTICALS INC


5-Apr-2013

Changes in Registrant's Certifying Accountant, Financial Statement


Item 4.01 Changes in Registrant's Certifying Accountant.

(a) As reported in the Original Form 8-K, the Company was advised by Ernst & Young, on February 18, 2013, that it would decline to stand for re-appointment as the Company's independent registered public accounting firm after completion of the audit for the year ended December 31, 2012, including the restatement of the Company's financial statements for the year ended December 31, 2011. Ernst & Young completed the audit of our financial statements for the fiscal year ended December 31, 2012, including the restatement of the Company's financial statements for the year ended 2011, on April 1, 2013 concurrent with the filing of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012 (2012 Annual Report). Therefore, the effective date of the Ernst & Young declination was April 1, 2013.

As noted in Item 4.02(a) of the Original Form 8-K, Ernst & Young's original report on the 2011 financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2011 filed on March 15, 2012 should no longer be relied upon, due to the restatement of the 2011 financial statements included in the Company's 2012 Annual Report filed April 1, 2013. When originally issued and as subsequently issued in connection with the restatement, Ernst & Young's audit reports on the financial statements for the years ended December 31, 2012 and 2011 did not contain any adverse opinion or disclaimer of opinion, and such reports were not qualified or modified as to any issues of uncertainty, audit scope or accounting principles.

In connection with the audits of the Company's financial statements for each of the two most recent fiscal years ended December 31, 2012 and 2011, and in the subsequent interim period through April 1, 2013, there were no disagreements with Ernst & Young on any matters of accounting principles or practices, financial statement disclosure, or auditing scope and procedures which, if not resolved to the satisfaction of Ernst & Young, would have caused Ernst & Young to make reference to the matter in their report.

The Company has provided Ernst & Young with a copy of this Amendment and requested that Ernst & Young provide the Company with a letter addressed to the Securities and Exchange Commission stating whether or not Ernst & Young agrees with the above disclosures. A copy of Ernst & Young's letter, dated April 5, 2013, is attached as Exhibit 16 to this Amendment.



Item 9.01 Financial Statements and Exhibits.

(d) The following exhibits are filed herewith:

Exhibit No.     Description of Exhibit

Exhibit 16      Letter from Ernst & Young LLP to the Securities and Exchange
                Commission dated April 5, 2013


  Add SCLN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SCLN - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.